Dylan Jovine's #1 Retirement Play for 2024

Register: My First LIVE Event in 5 Years! On Tuesday, November 19th, I'm breaking my "no webinars" rule and going LIVE at 8:00pm Eastern. You won't want to miss this event. I'm releasing my No. 1 Retirement Play in 2024. It has nothing to do with regular stocks, options, cryptos or any investment fads.

Click here now to register for "Our #1 Takeover Target for November" event.

Michael Brooks Biography and Net Worth

President of Edesa Biotech

Dr. Brooks was appointed President of Edesa in January 2019. He initially joined Edesa in September 2015 as Vice President, Corporate Development and Strategy. Prior to joining Edesa, Dr. Brooks held positions of increasing responsibility at Cipher Pharmaceuticals Inc (TSX:CPH) from 2010 to 2015 and served most recently as Director of Business Development. Prior to joining Cipher, Dr. Brooks was a Post-Doctoral fellow at the University of Toronto. Dr. Brooks holds a Hons B.Sc. degree in Microbiology and a PhD in Molecular Genetics from the University of Toronto. Dr. Brooks also holds a Master of Business Administration, degree from the Rotman School of Management where he was a Canadian Institute for Health Research (CIHR) Science to Business Scholar.

What is Michael J. Brooks' net worth?: The estimated net worth of Michael J. Brooks is at least $7,870.80 as of June 29th, 2022. Dr. Brooks owns 3,748 shares of Edesa Biotech stock worth more than $7,871 as of November 18th. This net worth approximation does not reflect any other assets that Dr. Brooks may own. Additionally, Dr. Brooks receives a salary of $439,270.00 as President at Edesa Biotech. Learn More about Michael J. Brooks' net worth.
How old is Michael J. Brooks?: Dr. Brooks is currently 46 years old. There are 2 older executives and no younger executives at Edesa Biotech. The oldest executive at Edesa Biotech is Dr. Pardeep Nijhawan FRCPC, M.D., CEO, Company Secretary & Director, who is 53 years old. Learn More on Michael J. Brooks' age.
What is Michael J. Brooks' salary?: As the President of Edesa Biotech, Inc., Dr. Brooks earns $439,270.00 per year. The highest earning executive at Edesa Biotech is Dr. Pardeep Nijhawan FRCPC, M.D., CEO, Company Secretary & Director, who commands a salary of $475,330.00 per year. Learn More on Michael J. Brooks' salary.
How do I contact Michael J. Brooks?: The corporate mailing address for Dr. Brooks and other Edesa Biotech executives is 100 SPY COURT, MARKHAM A6, L3R 5H6. Edesa Biotech can also be reached via phone at (289) 800-9600 and via email at [email protected]. Learn More on Michael J. Brooks' contact information.
Has Michael J. Brooks been buying or selling shares of Edesa Biotech?: Michael J. Brooks has not been actively trading shares of Edesa Biotech over the course of the past ninety days. Most recently, on Wednesday, June 29th, Michael J. Brooks bought 428 shares of Edesa Biotech stock. The stock was acquired at an average cost of $10.43 per share, with a total value of $4,464.04. Following the completion of the transaction, the president now directly owns 3,748 shares of the company's stock, valued at $39,091.64. Learn More on Michael J. Brooks' trading history.
Who are Edesa Biotech's active insiders?: Edesa Biotech's insider roster includes Michael Brooks (President), and Pardeep Nijhawan (CEO). Learn More on Edesa Biotech's active insiders.
Are insiders buying or selling shares of Edesa Biotech?: In the last year, Edesa Biotech insiders bought shares 1 times. They purchased a total of 5,000 shares worth more than $20,000.00. The most recent insider tranaction occured on March, 25th when CEO Pardeep Nijhawan bought 5,000 shares worth more than $20,000.00. Insiders at Edesa Biotech own 25.0% of the company. Learn More about insider trades at Edesa Biotech.
Information on this page was last updated on 3/25/2024.

Michael J. Brooks Insider Trading History at Edesa Biotech

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/29/2022	Buy	428	$10.43	$4,464.04	3,748
6/16/2022	Buy	428	$11.27	$4,823.56	3,320
5/25/2022	Buy	500	$12.18	$6,090.00	2,891
3/14/2022	Buy	178	$19.53	$3,476.34
3/10/2022	Buy	142	$22.54	$3,200.68
3/8/2022	Buy	178	$20.30	$3,613.40
3/25/2021	Buy	500	$36.33	$18,165.00	1,891
5/27/2020	Buy	357	$22.33	$7,971.81
1/8/2020	Buy	261	$28.77	$7,508.97	261

Michael J. Brooks Buying and Selling Activity at Edesa Biotech

Edesa Biotech Company Overview

Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in Covid-19 patients; and EB01, a topical vanishing cream containing non-steroidal anti-inflammatory compound that has completed Phase 2b clinical study to treat chronic allergic contact dermatitis. The company also develops EB02, an extension of secretory phospholipase 2 anti-inflammatory cream for treating erythema, swelling, and exudation associated with hemorrhoids disease; and EB06, an anti- chemokine ligand 10 (CXCL10) monoclonal antibody in vitiligo. It has a collaboration agreement with NovImmune SA to develop monoclonal antibodies targeting products containing toll-like receptor 4 and CXCL10 for therapeutic, prophylactic, and diagnostic applications in humans and animals; and Yissum Research Development Company for the development of products for therapeutic, prophylactic, and diagnostic uses in topical dermal and anorectal applications, as well as for the use in dermatologic and gastrointestinal conditions. The company was founded in 2015 and is headquartered in Markham, Canada.

Today's Range

Now: $2.10

$2.10

50 Day Range

MA: $3.76

$2.10

$4.64

2 Week Range

Now: $2.10

$2.09

$6.46

Volume

1,735 shs

Average Volume

14,160 shs

Market Capitalization

$6.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.84

Dylan Jovine's #1 Retirement Play for 2024

From Behind the Markets | Ad

Click here now to register for "Our #1 Takeover Target for November" event.

Michael Brooks Biography and Net Worth

What is Michael J. Brooks' net worth?

How old is Michael J. Brooks?

What is Michael J. Brooks' salary?

How do I contact Michael J. Brooks?

Has Michael J. Brooks been buying or selling shares of Edesa Biotech?

Who are Edesa Biotech's active insiders?

Are insiders buying or selling shares of Edesa Biotech?